Telegram RegisterThe public register of Telegram
Telegram profile photo for 제약/바이오/미용 원리버 Oneriver

Channel

제약/바이오/미용 원리버 Oneriver

@pharmbiohana

On this record: Growth · Engagement · Reactions · Stars · Posts · Polls · Citations · Cite this entry

29,924subscribers

+113 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of 10,000–31,623.

Register entry

Telegram ID-1001544338145
TypeChannel
Username@pharmbiohana
Created7 November 2021measured — cross-checked against a third-party dataset (ext.tg_channel)
First recorded6 August 2026
Last confirmed live16 August 2026
Measurements held10
Confirmed unchanged1 time, most recently 16 August 2026
On Telegramt.me/pharmbiohana

Growth

29,81129,92429,867.56 August 2026 — 29,811 subscribers7 August 2026 — 29,844 subscribers8 August 2026 — 29,838 subscribers9 August 2026 — 29,835 subscribers10 August 2026 — 29,833 subscribers11 August 2026 — 29,838 subscribers12 August 2026 — 29,879 subscribers13 August 2026 — 29,898 subscribers15 August 2026 — 29,905 subscribers16 August 2026 — 29,924 subscribers6 August 202616 August 2026
10 measurements spanning 10 days, net +113. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 29,794–29,941 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
16 Aug 2026, 22:1429,924+19
15 Aug 2026, 12:0629,905+7
13 Aug 2026, 23:4829,898+19
12 Aug 2026, 18:1729,879+41
11 Aug 2026, 15:2629,838+5
10 Aug 2026, 14:5129,833-2
9 Aug 2026, 11:3429,835-3
8 Aug 2026, 12:0129,838-6
7 Aug 2026, 14:3029,844+33
6 Aug 2026, 23:3229,811first reading

Engagement

131 posts held, back to 5 August 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 24 pagesof Telegram’s post history, 20 posts per page.

ERR · 30 days
16.8%
avg views ÷ 29,924 subscribers
Avg views / post
5,040
128 posts measured
Reaction rate
0.442%
reactions ÷ views · ER floor
Posts in window
131
of 131 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views— note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate. It is computed over the 125 of 128 measured posts that carry a reaction reading, and over those same posts' views.

What these figures were computed from
WindowRolling 30 days · latest post in window 16 August 2026
Posts held131 (5 August 202616 August 2026)
Views total644,874
Reactions total2,791
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken16 Aug 2026, 16:38 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

Reaction mix

2,791 reactions across 123 posts, in 12 distinct kinds. The most used accounts for 44.8% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
1,24944.8%
👍49217.6%
🤯46816.8%
😱1846.59%
💊1194.26%
🥰873.12%
👌682.44%
🤩511.83%
😍331.18%
❤‍🔥190.681%
🕊160.573%
50.179%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 125 of the 131 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 2,791reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 131 most recent posts we hold, published 5 August 2026 to 16 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Telegram Stars

Stars received
100
across the posts below
Posts paid on
1
of 128 we hold a reading for · 0.8%
Most on one post
100
single highest reading

A paid reaction is a reader spending Telegram Stars — bought with money — on a post by @pharmbiohana. Telegram publishes the count on the public post preview alongside ordinary reactions, and this register reads it there. It is the only figure on this site that measures money moving rather than attention.

Stars are not reactions, and the two are never added. They are rendered in the same strip on Telegram and counted in the same shape, but one is a tap and the other is a purchase. The reaction totals and the engagement rate elsewhere on this page exclude every figure in this section, and no rate here is computed against a reaction count.

This is not revenue, and we publish no currency figure. What a Star costs a reader and what it pays a channel are different numbers, Telegram takes a share we cannot observe, and the terms have changed. Converting a Star count into money would be an estimate dressed as a measurement, so the count is where we stop.

Counted over the 131 most recent posts we hold for this entry, published 5 August 2026 to 16 August 2026. Star counts above 1,000 reach us in Telegram’s short form and carry the same three-significant-figure rounding as everything else on this page.

Recent posts

16 Aug 2026, 15:53 UTC505 views4 reactionsread 16 August 2026
Forwarded from @bdragon0808

’손끝의혁명 수술의 미래‘라는 YTN 다큐멘터리.. 꼭 보시길 한국기업이 개발했음 https://youtu.be/V1478UgVpEM?si=-pPi2fXMCTTxhzwl

4

16 Aug 2026, 15:51 UTC599 views3 reactionsread 16 August 2026

https://m.blog.naver.com/kongin100/224380049426

2🤯1

16 Aug 2026, 01:15 UTC≈3,810 views5 reactionsread 16 August 2026
Forwarded from @G2strategy

미국인 취미 관련 소비 비중은 코로나 시기 정점을 상회 ======================== ~ Hobby-related spending just hit a record share of U.S. goods consumption — nearly 5%, beating even the pandemic peak ~ Sales at sporting goods, hobby, musical instrument, and book stores jumped +11.3% year-over-year in May https://x.com/Hedgeye/status/2088579201683411138

3😱2

15 Aug 2026, 15:05 UTC≈6,390 views35 reactionsread 16 August 2026

증시각도기 곽상준 대표님과 현재 시장에 대해서, 그리고 코스닥에 대해서 다시한번 재밌는 이야기 많이 나누어보았습니다! 연휴 즐겁게 보내세요:) https://youtu.be/Q19fquCRDeo?si=8QZm1tYgCnAgOjZb

30😱4🤯1

14 Aug 2026, 10:52 UTC≈5,920 views27 reactionsread 16 August 2026

📢 [원리버 강하나] A/S 코스 자료집, 지금도 무료 확인가능 이번 주 A/S 코스에는 [바이오 상반기 대동여지도]와 [원리버 TOP PICK 족보]가 공개됐습니다. 상반기 바이오 시장의 흐름부터 하반기에 주목해야 할 종목과 포인트까지, 지금도 모두 확인하실 수 있습니다. --- 🚨 그리고 다음 주에는 한 단계 더 실전으로 들어갑니다. ✅ 시그널랩 주간 공부방 코멘트 요약집 👉 한 주간 쏟아진 바이오 이슈를 주 단위로 정리하고, ✅ 바이오 투자 용어사전 👉 뉴스와 공시를 볼 때 막히는 용어와 개념을 쉽게 풀어드립니다. 이번 주 자료집을 놓치셨다면 지금 확인하고, 다음 주 공개될 자료집까지 이어서 받아보세요! ⬇️ A/S 코스 신청하고 자료집 확인하기 🔗 https://fanding.me/3UrbXn6

16🤯8😱3

14 Aug 2026, 10:52 UTC≈4,920 views18 reactionsread 16 August 2026
Forwarded from @insidertrackingPhoto

코스피 야간선물

13🤯5

14 Aug 2026, 09:54 UTC≈4,320 views24 reactionsread 16 August 2026
Forwarded from @TNBfolioPhoto

코스닥 신용잔고

🤩17🤯43

14 Aug 2026, 08:25 UTC≈4,500 views30 reactionsread 16 August 2026
Forwarded from @darthacking

2026.08.14 15:40:21 기업명: 리브스메드(시가총액: 1조 1,592억) A491000 보고서명: 반기보고서 (2026.06) 잠정실적 : N 매출액 : 125억(예상치 : 154억, -18.8%) 영업익 : -122억(예상치 : -71억, -71.7%) 순이익 : -110억(예상치 : -47억, -134.6%) **최근 실적 추이** (기간/ 매출/ 영업익/ 순익) 2026.2Q 125억/ -122억/ -110억 2026.1Q 103억/ -84억/ -59억 2025.4Q 166억/ -60억/ -57억 2025.3Q 134억/ -45억/ -40억 2025.2Q 114억/ -54억/ -69억 공시링크: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260814002414

😱18👌54🤯3

14 Aug 2026, 08:16 UTC≈4,140 views14 reactionsread 16 August 2026
Forwarded from @SHIDGL

[리가켐바이오 2026년 2분기 실적발표] 안녕하세요 리가켐바이오 IR팀입니다. 조금 전 공시를 통해 당사 2분기 실적을 발표했습니다. 이와 관련한 2분기 실적 IR자료 및 주요 요약 공유드립니다. (2분기 실적 컨퍼런스 콜은 진행되지 않습니다 - 7월 Global R&D Day 행사로 대체, 3분기부터는 다시 컨퍼런스 콜 진행 예정) ■ 2분기 실적 (별도 기준) · 매출액 71억원 / 영업손실 764억원 · 신규 ADC 기술이전 계약 부재 및 후속 마일스톤 유입 제한으로 기술이전 매출 40억원 (-86% YoY) · 연구개발비 765억원 (+90% YoY) — 임상단계 프로젝트 수 확대에 따른 것으로, 연간 연구개발비 증가는 불가피 ■ 3분기 매출 회복 예상 요인 · 오노 LCB97(L1CAM) 첫 환자 투여 마일스톤 수령 확정 (8

10😱31

14 Aug 2026, 07:00 UTC≈4,290 views2 reactionsread 16 August 2026
Forwarded from @bbong_ttaPhoto

Photo, posted without a caption

2

14 Aug 2026, 06:59 UTC≈3,610 views8 reactionsread 16 August 2026
Forwarded from @growthbio

🧬 에이프릴바이오, 에보뮨 마일스톤 차곡차곡…"임상 기준 충족" https://news.bizwatch.co.kr/article/healthcare/2026/08/14/0014 💊 임상 진전으로 50만달러 추가 수령 에보뮨으로부터 올해 1분기 마일스톤 50만달러 수령 약 7.25억원을 매출로 인식해 상반기 매출 전액 차지 2a상 완료와 계약상 임상 기준 충족에 따른 기술료 💊 EASI 55% 감소로 개념증명 성공 중등도·중증 아토피 환자 70명 대상 2a상 완료 12주차 EASI는 투여군 55% 감소, 위약군은 22% 감소 약물 관련 중대한·중증 이상반응이나 치료 중단도 미보고 💊 누적 기술료 약 236억원 확보 2024년 계약금 1,500만달러 수령 2025년 2a상 개시 마일스톤 150만달러 추가 현재까지 누적 1,700

5😱3

14 Aug 2026, 04:56 UTC≈4,250 views7 reactionsread 16 August 2026
Forwarded from @BBAinsights

삼성바이오로직스 노사가 장기화된 임단협 해결을 위해 사후조정 절차를 수용했습니다. 양측은 고용노동부 산하 중부지방고용노동청이 제안한 사후조정에 합의하고 관련 서류를 인천지방노동위원회에 제출할 예정입니다. 임금 인상과 성과급, 복리후생 등을 둘러싼 이견으로 교섭이 장기화됐으며, 올해 4월 부분파업과 5월 창사 첫 전면파업도 이어졌습니다. 이번 합의로 노동위원회가 중재에 참여하면서 장기간 이어진 임단협이 타결 국면으로 전환될 가능성이 커졌습니다. 노사는 조정위원 구성이 마무리되는 대로 협상을 이어갈 계획입니다. 더파마뉴스에서 보기 https://thepharmanews.net/article/samsung-biologics-labor-negotiation-post-mediation?utm_source=telegram 더파마뉴스 텔레그램 ht

4🤯3

Showing the 12 most recent of 131 posts we hold for @pharmbiohana. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Polls

The poll we hold for this entry, as Telegram rendered it when we read the post. A poll’s figures keep moving after that, so each one is dated.

11 Aug 2026, 08:34 UTCAnonymous Poll3,720 voters approx.

‘전닉 랠리 시즌2 or 시체 줍줍 코스닥 시즌1‘

  1. 죽어도 전닉41%
  2. 코스닥 1000pt59%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

Percentages only — there are no per-option vote counts here, because Telegram publishes none.The public post preview gives each option’s share and a single voter total, and nothing else. Multiplying one by the other would produce a per-option tally that looks measured and is not: the shares are rounded to whole numbers before we ever see them. We print what was published and leave the column that does not exist empty.

The shares need not add up to 100.Rounding alone puts many polls at 99 or 101. A poll that allows more than one answer per voter runs well past 100 by design, and several here do. The bars are drawn against a fixed 100% track at each option’s own percentage rather than normalised to the total, so a poll that exceeds it shows that it does instead of being quietly rescaled.

Read from the 131 most recent posts we hold, published 5 August 2026 to 16 August 2026. Telegram labels each poll by kind — an anonymous poll, a quiz, a closed set of final results — and that label is reproduced rather than paraphrased.

Citation-graph rank

Citation-graph rank — 165,771 of 1,481,502entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.

Forward network

Republishes

Channels on the register whose posts this channel has forwarded.

AWAKE - 실시간 주식 공시 정리채널
@darthacking · 64,808
19 posts
더파마 뉴스·인사이트| THE PHARMA
@BBAinsights · 941
7 posts
한투증권 미국/중국전략 정정영
@G2strategy · 15,467
3 posts
묻따방 🐕
@mootda · 19,618
3 posts
올릭스(주) - OliX Pharmaceuticals
@olix_official · 3,723
3 posts
[신한 리서치본부] 화장품/의복
@shinhanconsumer · 1,499
3 posts
알테오젠 IR
@alteogenIR · 9,578
2 posts
돼지바
@bbong_tta · 12,699
2 posts
한양증권 제약/바이오 오병용
@bdragon0808 · 13,278
2 posts
BRILLER
@BRILLER_Research · 18,303
2 posts
조기주식회 공부방
@EarlyStock1 · 24,381
2 posts
지아이이노베이션 공식 IR
@GIInnovation · 1,946
2 posts
한경바이오인사이트
@hkbioinsight · 4,285
2 posts
아이엠바이오로직스 IR/PR
@imbiologics_official · 512
2 posts
미국 주식 인사이더 🇺🇸 (US Stocks Insider)
@insidertracking · 69,601
2 posts
리브스메드
@livsmed · 715
2 posts
[한투증권 투자전략 김대준]
@strategy_kis · 10,130
2 posts
Yeouido Lab_여의도 톺아보기
@Yeouido_Lab · 43,302
2 posts
다올 의료기기/화장품 박종현
@alexppark · 8,291
1 post
에이프릴바이오 IR채널: 리레이팅 2026
@aprilbioipr · 4,402
1 post
바이오스펙테이터
@biospectatorT · 5,869
1 post
간절한 투자스터디카페
@desperatestudycafe · 18,871
1 post
디앤디파마텍 공식 IR 채널
@dndpharmatech · 3,580
1 post
🧬바이오섹터 분석🧬 [그로쓰리서치]
@growthbio · 13,328
1 post
습관이 부자를 만든다. 🧘
@habit4117 · 27,575
1 post
한화투자증권 음식료/화장품 한유정
@hanwha_yujunghan · 913
1 post
허혜민의 제약/바이오 소식통
@huhpharm · 23,912
1 post
인상주의 투자 인생 업그레이드노트
@insangnism · 11,255
1 post
아스달 (IPO&스몰캡 달인)
@iposmallcap · 2,490
1 post
이지스 리서치 (주식 투자 정보 텔레그램)
@jeilstock · 26,464
1 post
JW 공식 PR/IR 채널
@JWofficialchannels · 266
1 post
김찰저의 관심과 생각 저장소
@kimcharger · 24,869
1 post
요약하는 고잉
@one_going · 46,187
1 post
용산의 현인
@petrojimmy · 6,993
1 post
BUYagra
@psychotherapy101 · 5,965
1 post
에스바이오메딕스 • S.BIOMEDICS • official
@sbiomedics · 1,317
1 post
리가켐바이오 IR/PR 공식 채널
@SHIDGL · 10,146
1 post
팔칠사공스토너 실전투자 인사이트
@stoner8740 · 11,026
1 post
더바이오 뉴스룸
@thebio111 · 6,495
1 post
TNBfolio
@TNBfolio · 24,635
1 post
미국 제약-바이오 주식/약장수
@yakjangsu · 11,461
1 post
YM리서치
@ym_research · 39,768
1 post

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 16 August 2026 — this entry's latest reading, not the date you are reading this.

“제약/바이오/미용 원리버 Oneriver” (@pharmbiohana), 29,924 subscribers as measured 16 August 2026. Telegram Register, tgregister.com/channel/pharmbiohana.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.